Prognostic factors for patients with sinonasal undifferentiated carcinoma.
نویسندگان
چکیده
Originally described in 1986, sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive malignancy of the nasal cavity and paranasal sinuses. Although the majority of patients diagnosed with SNUC have a poor outcome, there are patients that, with treatment, do not develop recurrences and are essentially cured of their disease. Currently, there are no prognostic factors in the literature that can differentiate these two groups of patients.
منابع مشابه
Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Objective Sinonasal undifferentiated carcinoma is a rare and aggressive malignancy of the nasal cavity and paranasal sinuses. Multi-institutional studies examining outcomes of combined modality treatment versus other treatment modalities have not been performed. The objective of our study was to present outcomes for multimodality therapy through use of the National Cancer Database. Study Design...
متن کاملMultimodality treatment for sinonasal neuroendocrine carcinoma.
BACKGROUND Neuroendocrine carcinoma (NEC) of the paranasal sinuses is rare, accounting for 5% of sinonasal malignancies. The purpose of this study was to assess prognostic factors and survival rates for sinonasal NEC. METHODS A retrospective review of patients with NEC treated from 1990 to 2004 was performed. Patient demographics, TNM classification, treatment modality, recurrences, and survi...
متن کاملSinonasal undifferentiated carcinoma: an update.
PURPOSE OF REVIEW Sinonasal undifferentiated carcinoma is a rare and extremely malignant tumor of the paranasal sinuses. Historically, treatment outcomes have been poor. This review presents recent data on the management of sinonasal undifferentiated carcinoma and examines treatment trends that may result in improved locoregional control and survival. RECENT FINDINGS Patients who receive aggr...
متن کاملSinonasal undifferentiated carcinoma: a 13-year experience at a single institution.
We present our experience with sinonasal undifferentiated carcinoma at the University of Michigan over 13 years and review prior published data. We conducted a retrospective review of 19 patients who presented to a tertiary care academic center multidisciplinary skull base clinic with sinonasal undifferentiated carcinoma between 1995 and 2008. Overall survival was 22% at 5 years, and the estima...
متن کاملMatrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors
Background & Objective: Matrix metalloproteinases-9 (MMP-9) is one of the most important enzymes to breakdown extracellular matrix which plays a major role in tumor invasion and metastasis. This study aimed to determine tumor MMP-9 expression in non-small-cell lung carcinoma (NSCLC) and whethe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Laryngoscope
دوره 120 Suppl 4 شماره
صفحات -
تاریخ انتشار 2010